REFERENCES
  1. Pippard MJ. Microcytic anaemias in childhood and iron-refractory iron deficiency anaemia. Br J Haematol 2017;177:167-168.
  2. Henney MM, Finberg KE. Iron-refractory iron deficiency anemia (IRIDA).Hemat Oncol Clin North Am 2014;28:637-652.
  3. Hershko C, Camaschella C. How I treat unexplained refractory iron deficiency anemia. Blood 2014;123:326-335.
  4. Finberg KE, Henney MM, Campagna DR, et al. Mutations inTMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).Nat Genet 2008;40:569-571.
  5. De Falco L, Totaro F, Nai A, et al. Novel TMPRSS6mutations associated with iron-refractory iron deficiency anemia (IRIDA). Hum Mutat 2010;31:e1390-1405.
  6. De Falco L, Silverstri L, Kannengiesser C, et al. Functional and clinical impact of novel Tmprss6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies. Hum Mutat 2014;35:1321-1329.
  7. Khuong-Quang D, Schwartzentruber J, Westerman M, et al. Iron refractory iron deficiency anemia: Presentation with hyperferritinemia and response to oral iron therapy. Pediatrics 2013;131:e620.
  8. Choi HS, Yang HR, Song SH, et al. A novel mutation Gly603Arg ofTMPRSS6 in a Korean female with iron-refractory iron deficiency anemia. Pediatr Blood Canc 2012;58:640-642.
  9. Sato T, Iyama S, Murase K, et al. Novel missense mutation in the TMPRSS6 gene in a Japanese female with iron-refractory iron deficiency anemia. Int J Hematol 2011;94:101-103.
  10. Guillem F, Lawson S, Kannengiesser C, et al. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 2008;112:2089-2092.
  11. Pellegrino RM, Coutinho M, D’Ascola D, et al. Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form. Br J Haemat 2012;158:667-672.
  12. Silvestri L, Guillem F, Nai A, et al. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia. Blood2009;113:5605-5609.
  13. Belot A, Gourbeyre O, Fay A, et al. LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA. Haematologica 2020;105:e385-388.